CYP2B6 and Abnormal renal physiology: Several studies have revealed that patients with renal dysfunction exhibit reduced non-renal clearance and altered bioavailability of drugs predominantly metabolized by the liver, perhaps reflecting a selective decrease in hepatic p450 activity [15,30,31,32].